Journal of Jilin University(Medicine Edition) ›› 2026, Vol. 52 ›› Issue (2): 507-512.doi: 10.13481/j.1671-587X.20260223
• Research in clinical medicine • Previous Articles Next Articles
Yuyang LI,Xiang LI,He SHI,Yiwen QIN,Zhaorong XIAO,Sihao CHEN,Cong ZHAO(
),Weiwei LIU(
)
Received:2025-05-08
Accepted:2025-06-15
Online:2026-03-28
Published:2026-04-15
Contact:
Cong ZHAO,Weiwei LIU
E-mail:10124566@qq.com;liuweiw@jlu.edu.cn
CLC Number:
Yuyang LI,Xiang LI,He SHI,Yiwen QIN,Zhaorong XIAO,Sihao CHEN,Cong ZHAO,Weiwei LIU. Analyses of etiology characteristics and risk factors for postoperative infection in patients underwent oral and maxillofacial surgery[J].Journal of Jilin University(Medicine Edition), 2026, 52(2): 507-512.
Tab.1
Variables from clinical data in patients and their assignments"
| Variable | Assignment |
|---|---|
| Age (year) | 0:<60,1:≥60 |
| Surgical risk assessment level (NNIS score) | 0:<2,1:≥2 |
| Surgical complexity (number of surgical procedures) | 0:<3,1:≥3 |
| Intraoperative blood loss (mL) | 0:<200,1:≥200 |
| Duration of surgery (h) | 0:<3,1:≥3 |
| Placement of post-operative drainage device | 0:No,1:Yes |
| Implantation of medical device | 0:No,1:Yes |
| Performance of temporary tracheotomy | 0:No,1:Yes |
Tab.2
Distributions of pathogenic bacteria in post-operative infection patients"
| Pathogenic bacteria | Count | Composition ratio (η/%) |
|---|---|---|
| Total | 209 | 100.00 |
| Gram-positive bacteria | 84 | 40.19 |
| Staphylococcus aureus | 6 | 2.87 |
| Staphylococcus epidermidis | 15 | 7.18 |
| Streptococcus constellatus | 17 | 8.13 |
| Streptococcus gallolyticus | 12 | 5.74 |
| Streptococcus salivarius | 9 | 4.31 |
| Streptococcus anginosus | 4 | 1.91 |
| Enterococcus faecalis | 12 | 5.74 |
| Gemella morbillorum | 9 | 4.31 |
| Gram-negative bacteria | 120 | 57.42 |
| Enterobacter cloacae | 29 | 13.88 |
| Serratia marcescens | 12 | 5.74 |
| Klebsiella oxytoca | 7 | 3.35 |
| Klebsiella pneumoniae | 5 | 2.39 |
| Acinetobacter baumannii | 5 | 2.39 |
| Proteus mirabilis | 5 | 2.39 |
| Pseudomonas aeruginosa | 51 | 24.40 |
| Eikenella corrodens | 3 | 1.44 |
| Capnocytophaga sputigena | 3 | 1.44 |
| Fungi | 5 | 2.39 |
| Candida albicans | 5 | 2.39 |
Tab.3
Drug susceptibilities of Gram-positive bacteria from clinical specimens"
Antibacterial drug | Staphylococcus (n=21) | Streptococcus (n=42) | Enterococcusfaecalis (n=12) |
|---|---|---|---|
| Penicillin | 3(14.3) | 39(92.9) | 12(100.0) |
| Oxacillin | 3(14.3) | - | - |
| Ampicillin | - | 27(64.3) | 12(100.0) |
| Ceftriaxone | - | 42(100.0) | - |
| Cefepime | - | 39(92.9) | - |
| Meropenem | - | 42(92.9) | - |
| Vancomycin | 21(100.0) | 42(100.0) | 12(100.0) |
| Chloramphenicol | 15(71.4) | 42(100.0) | 12(100.0) |
| Daptomycin | 21(100.0) | 42(100.0) | 12(100.0) |
| Linezolid | 21(100.0) | 42(100.0) | 12(100.0) |
| Levofloxacin | 9(42.9) | 33(78.6) | - |
| Ciprofloxacin | 9(42.9) | - | - |
| Moxifloxacin | 15(71.4) | - | - |
| Tetracycline | 15(71.4) | 6(14.3) | - |
| Azithromycin | 3(14.3) | 3(7.1) | - |
| Erythromycin | 3(14.3) | 3(7.1) | 0(0) |
| Clindamycin | 6(28.6) | 9(21.4) | 0(0) |
| Gentamicin | 12(57.1) | - | 12(100.0) |
| Doxycycline | 21(100.0) | - | 3(25.0) |
Tab.4
Drug susceptibilities of Gram-negative bacteria from clinical specimens"
| Antibacterial drug | Enterobacteriaceae (n=63) | Pseudomonas (n=51) |
|---|---|---|
| Piperacillin/Tazobactam | 63(100.0) | 51(100.0) |
| Ticarcillin/Clavulanic acid | 57(90.5) | 51(100.0) |
| Cefotaxime | 45(71.4) | - |
| Ceftazidime | 54(85.7) | 51(100.0) |
| Cefepime | 60(95.2) | 51(94.1) |
| Imipenem | 63(100.0) | 48(100.0) |
| Meropenem | 63(100.0) | 51(100.0) |
| Levofloxacin | 57(90.5) | 51(100.0) |
| Ciprofloxacin | 51(81.0) | 51(100.0) |
| Gentamicin | 60(95.2) | 51(100.0) |
| Tobramycin | 57(90.5) | 51(100.0) |
| Minocycline | 57(90.5) | - |
Tab.5
Clinical data of patients in two groups"
| Variable | Non-infection group (n=332) | Infection group (n=130) | χ2 | P |
|---|---|---|---|---|
| Age (year) | ||||
| <60 | 235(65.7) | 75(61.5) | 7.252 | 0.007 |
| ≥60 | 97(27.1) | 55(38.5) | ||
| Surgical risk assessment level | ||||
| <2 | 205(57.2) | 38(29.2) | 39.616 | <0.001 |
| ≥2 | 127(35.5) | 92(70.8) | ||
| Surgical complexity | ||||
| <3 | 172(48.2) | 22(16.9) | 46.670 | <0.001 |
| ≥3 | 160(44.6) | 108(83.1) | ||
| Intraoperative blood loss (mL) | ||||
| <200 | 158(32.8) | 46(35.4) | 5.644 | 0.017 |
| ≥200 | 174(27.1) | 84(64.6) | ||
| Duration of surgery (h) | ||||
| <3 | 207(57.5) | 36(27.7) | 45.005 | <0.001 |
| ≥3 | 125(34.9) | 94(72.3) | ||
| Placement of post-operative drainage device | ||||
| No | 176(53.0) | 26(20.0) | 41.376 | <0.001 |
| Yes | 156(47.0) | 104(80.0) | ||
| Implantation of medical device | ||||
| No | 186(51.8) | 50(38.5) | 11.531 | <0.001 |
| Yes | 146(41.0) | 80(61.5) | ||
| Performance of temporary tracheotomy | ||||
| No | 270(81.3) | 76(38.5) | 25.971 | <0.001 |
| Yes | 62(18.7) | 54(41.5) |
Tab.6
Multivariate Logistic regression analysis on influencing factors of postoperative infection"
| Variable | β | SE | Wald χ2 | OR | 95%CI | P |
|---|---|---|---|---|---|---|
| Surgical complexity (≥3) | 1.367 | 0.598 | 5.229 | 3.924 | 1.216-12.664 | 0.022 |
| Intraoperative blood loss (≥200 mL) | 2.653 | 0.939 | 7.978 | 14.197 | 2.253-89.477 | 0.005 |
| Surgical risk assessment level (≥2) | 1.701 | 0.535 | 10.109 | 5.478 | 1.920-15.628 | 0.001 |
| [1] | LEE J S, ROSER S M, AZIZ S R. Oral and maxillofacial surgery in low-income and middle-income countries[J]. Oral Maxillofac Surg Clin North Am, 2020, 32(3): 355-365. |
| [2] | YU X L, PENG J H, CHANG Q, et al. Important issues on the prevention of surgical site infections and the management of prophylactic antibiotics[J]. World J Gastrointest Surg, 2025, 17(4): 102144. |
| [3] | FORRESTER J D, SESHADRI A, PATEL N, et al. Surgical infection society guidelines for use of antimicrobial agent-coated suture to reduce the risk of surgical site infection after abdominal operation[J]. Surg Infect, 2025, 26(6): 441-450. |
| [4] | CONSORTI G, CIRIGNACO G, MONARCHI G, et al. The role of professional oral hygiene in enhancing outcomes of maxillofacial trauma surgery[J]. J Stomatol Oral Maxillofac Surg, 2025, 126(4S): 102269. |
| [5] | BADIA J M. When monitoring is not enough. Results of postoperative infection prevention bundles and a proposal[J]. Cir Esp, 2022, 100(11): 669-672. |
| [6] | GOSWAMI K, STEVENSON K L, PARVIZI J. Intraoperative and postoperative infection prevention[J]. J Arthroplasty, 2020, 35(3S): S2-S8. |
| [7] | COLE J. Antimicrobial resistance: a ‘rising tide’ of national (and international) risk[J]. J Hosp Infect, 2016, 92(1): 3-4. |
| [8] | DAVIES S C, FOWLER T, WATSON J, et al. Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance[J]. Lancet, 2013, 381(9878): 1606-1609. |
| [9] | NISHIHAMA S, KAWADA-MATSUO M, LE M N, et al. Oral colonization of antimicrobial-resistant bacteria in home health care participants and their association with oral and systemic status[J]. Sci Rep, 2025, 15(1): 5776. |
| [10] | DAMMLING C, ABRAMOWICZ S, KINARD B. Current concepts in prophylactic antibiotics in oral and maxillofacial surgery[J]. Oral Maxillofac Surg Clin North Am, 2022, 34(1): 157-167. |
| [11] | 武月华, 张 爽, 王泽正. 螺旋CT及三维重建技术诊断颌面部骨折的价值[J]. 中国医学物理学杂志, 2024, 41(11): 1357-1360. |
| [12] | RIBEIRO E D, DE SANTANA I H G, VIANA M R M, et al. Optimal treatment time with systemic antimicrobial therapy in odontogenic infections affecting the jaws: a systematic review[J]. BMC Oral Health, 2025, 25(1): 253. |
| [13] | 董雪红, 乔 彬. 康复新液对口腔颌面肿瘤外科手术患者术后口腔感染的预防效果观察[J]. 肿瘤基础与临床, 2020, 33(4): 342-345. |
| [14] | 蔡永鹏, 高 翔, 李 勇, 等. 口腔颌面部恶性肿瘤患者发生术后感染的危险因素分析及预防措施[J]. 现代医药卫生, 2024, 40(18): 3072-3077. |
| [15] | MILIC T, RAIDOO P, GEBAUER D. Antibiotic prophylaxis in oral and maxillofacial surgery: a systematic review[J]. Br J Oral Maxillofac Surg, 2021, 59(6): 633-642. |
| [16] | ZIRK M, MARKEWITSCH W, PETERS F, et al. Osteosynthesis-associated infection in maxillofacial surgery by bacterial biofilms: a retrospective cohort study of 11 years[J]. Clin Oral Investig, 2023, 27(8): 4401-4410. |
| [17] | MASCITTI M, TOGNI L, TROIANO G, et al. Beyond head and neck cancer: the relationship between oral microbiota and tumour development in distant organs[J]. Front Cell Infect Microbiol, 2019, 9: 232. |
| [18] | LAFFONT C, WECHSLER T, KÜMMERLI R. Interactions between Pseudomonas aeruginosa and six opportunistic pathogens cover a broad spectrum from mutualism to antagonism[J]. Environ Microbiol Rep, 2024, 16(5): e70015. |
| [19] | ASSAEL L A. Nosocomial infection and fomites in oral and maxillofacial surgery practice[J]. J Oral Maxillofac Surg, 2005, 63(7): 889-890. |
| [20] | WANG S S, TANG Y L, PANG X, et al. The maintenance of an oral epithelial barrier[J]. Life Sci, 2019, 227: 129-136. |
| [21] | SINGH V, SINGH A K. Oral mucositis[J]. Natl J Maxillofac Surg, 2020, 11(2): 159-168. |
| [22] | BRATIĆ V, MIHALJEVIĆ S, VERZAK Ž, et al. Prophylactic application of antibiotics selects extended-spectrum β-lactamase and carbapenemases producing Gram-negative bacteria in the oral cavity[J]. Lett Appl Microbiol, 2021, 73(2): 206-219. |
| [23] | AGGARWAL R, MAHAJAN P, PANDIYA S, et al. Antibiotic resistance: a global crisis, problems and solutions[J]. Crit Rev Microbiol, 2024, 50(5): 896-921. |
| [1] | Xiao LI,Li WANG,Wen WU,Rui WANG,Aiying ZHANG,Shuo ZHANG,Rujia JIANG,Yaning MENG. Clinical outcomes and risk factors analysis on infection in patients with bullous pemphigoid [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1312-1317. |
| [2] | Jiahui FENG,Renjie LIU,Xuan CHEN. Analysis on risk factors of development of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 763-769. |
| [3] | Suzhen YUAN,Yan JIN,Wenwen WANG. Analysis on clinical characteristics of patients with ovarian clear cell carcinoma and ovarian endometriosis [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1677-1682. |
| [4] | Honghong LI,Na YU,Minghao SHI,Ying SUN,Yao LI,Zhongjun SHEN,Xiaoyi LIU,Liyan ZHAO. Predictive value of new thrombotic risk assessment model for venous thromboembolism in patients with malignant tumors [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1390-1399. |
| [5] | Jiayuan YU,Di ZHAO,Xin JIANG,Jing XU,Lili JIANG,Hongyu JIANG. Association analysis on peripheral blood lymphocyte subsets and occurrence of carotid atherosclerosis [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1400-1405. |
| [6] | Peng QI,Xianying MENG,Meihua PIAO,Qiang ZHANG. Network Meta-analysis on risk factors of recurrence of papillary thyroid microcarcinoma [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1504-1512. |
| [7] | Xiunan FENG,Lu CHEN,Yu LONG,Zhenyu JIANG,Ling ZHAO. Analysis on clinical characteristics and risk factors of patients with Sjogren’s syndrome complicated with interstitial lung disease [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1513-1518. |
| [8] | Xue DONG, Jinfeng ZANG, Caifeng XU, Hebing LIU, Zhaohua CHENG. Construction and validation of risk prediction model of enteral nutrition feeding intolerance of patients with severe acute pancreatitis [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1586-1592. |
| [9] | Tong SHEN,Yang WANG,Wei JIN,Zhihui LIN,Li YAN. Risk factors analysis and risk model construction of cognitive frailty in elderly patients with chronic diseases [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1304-1309. |
| [10] | Mingfei JU,Chao LIU,Zhigang MA,Juan ZHAO,Tu WANG,Zhihao WANG. Predictive value of residual cholesterol in occurrence of patients with acute coronary syndrome [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 765-769. |
| [11] | Lianyuan WANG,Yi YANG,Huiwen CONG,Haohua WANG,Qihan BAO,Chengsheng LI,Liwen ZHOU,Zichen DING,Yanli LI,Fuyan SHI,Suzhen WANG. Bayesian quantile regression joint model analysis on risk factors of Alzheimer’s disease in people with different MMSE scores [J]. Journal of Jilin University(Medicine Edition), 2023, 49(2): 395-401. |
| [12] | Shan GAO,Yutong WANG,Minqiu LU,Lei SHI,Bin CHU,Yuehua DING,Mengzhen WANG,Li BAO. Analysis on causes for early death and its risk factors of patients with multiple myeloma in era of novel drugs [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 783-789. |
| [13] | LI Ting, CHEN Yuanyuan, SUN Hongshuai, YU Xiuyan, WU Xuefeng. Application of hematology-related indexes in early diagnosis of bacterial infectionof tumor patients in ICU [J]. Journal of Jilin University(Medicine Edition), 2020, 46(04): 816-821. |
| [14] | ZHANG Haolong, YU Zhentao, GAO Zihan, WU Yuanyu, FANG Xuedong. Related risk factors and clinical treatment of patients with PGS after gastric cancer operation [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 673-677. |
| [15] | JIANG Rui, LIU Fang, PAN Yueji, LU Boyang, HOU Lulu, WANG Chunmei, JIA Hui, SHI Xiaoru. Screening and analysis of dry eye in eye discomfort patients in Jilin Province [J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 832-838. |